Cargando…

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies

BACKGROUND: Efforts to understand the impact of SARS-CoV-2 variants, vaccine status, and treatment on the development and persistence of Long COVID have intensified. METHODS: We report 4 sequential cases from a post-COVID cohort study demonstrating variability in outcomes following differentially ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peluso, Michael J., Anglin, Khamal, Durstenfeld, Matthew S., Martin, Jeffrey N., Kelly, J. Daniel, Hsue, Priscilla Y., Henrich, Timothy J., Deeks, Steven G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pathogens and Immunity 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254867/ https://www.ncbi.nlm.nih.gov/pubmed/35800257 http://dx.doi.org/10.20411/pai.v7i1.518

Ejemplares similares

ROLE OF ANTIBODIES, INFLAMMATORY MARKERS, AND ECHOCARDIOGRAPHIC FINDINGS IN POST-ACUTE CARDIOPULMONARY SYMPTOMS AFTER SARS-COV-2 INFECTION
por: Durstenfeld, Matthew, et al.
Publicado: (2022)

Findings From Mayo Clinic’s Post-COVID Clinic: PASC Phenotypes Vary by Sex and Degree of IL-6 Elevation
por: Durstenfeld, Matthew S., et al.
Publicado: (2022)

CE-541-04 CARDIAC ARRHYTHMIAS IN POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION ASSESSED BY AMBULATORY RHYTHM MONITORING
por: Hill, Christopher, et al.
Publicado: (2022)

Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis
por: Durstenfeld, Matthew S., et al.
Publicado: (2022)

Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
por: Bodansky, Aaron, et al.
Publicado: (2023)

Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients
por: Bodansky, Aaron, et al.
Publicado: (2023)

The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
por: Buck, Amanda M., et al.
Publicado: (2023)

Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection
por: Peluso, Michael J., et al.
Publicado: (2023)

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
por: Durstenfeld, Matthew S., et al.
Publicado: (2022)

Nirmatrelvir/ritonavir as a possible treatment for Long-COVID
por: Catalán, Ignacio Pérez, et al.
Publicado: (2023)

Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
por: Cohen, Alison K., et al.
Publicado: (2023)

Benefits of nirmatrelvir–ritonavir remain unproven for some populations
por: McDonald, Emily G., et al.
Publicado: (2022)

Seeing Is Believing: Nuclear Imaging of HIV Persistence
por: Henrich, Timothy J., et al.
Publicado: (2019)

Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
por: Vazquez, Sara R., et al.
Publicado: (2022)

Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study
por: Congdon, Seth, et al.
Publicado: (2023)

Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients
por: Fung, Kin Wah, et al.
Publicado: (2023)

Chronic viral coinfections differentially affect the likelihood of developing long COVID
por: Peluso, Michael J., et al.
Publicado: (2023)

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
por: Peluso, Michael J., et al.
Publicado: (2022)

Coronary Assessment in Heart Failure within a Safety-Net Setting: Disparities and Outcomes
por: Durstenfeld, Matthew S., et al.
Publicado: (2023)

A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19)
por: Peluso, Michael J, et al.
Publicado: (2020)

Early clues regarding the pathogenesis of long-COVID
por: Peluso, Michael J., et al.
Publicado: (2022)

COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
por: Coulson, J.M., et al.
Publicado: (2022)

The Remarkable Selectivity of Nirmatrelvir
por: Duveau, Damien Y., et al.
Publicado: (2022)

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
por: Peluso, Michael J, et al.
Publicado: (2021)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
por: Hellmuth, Joanna, et al.
Publicado: (2021)

Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
por: Peluso, Michael J., et al.
Publicado: (2022)

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
por: Yin, Kailin, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Impact of HIV Infection on COVID-19 Outcomes Among Hospitalized Adults in the U.S.
por: Durstenfeld, Matthew S., et al.
Publicado: (2021)

Association of Right Ventricular Dilation on Echocardiogram With In-Hospital Mortality Among Patients Hospitalized With COVID-19 Compared With Bacterial Pneumonia
por: Sun, Kaiwen, et al.
Publicado: (2023)

Factors Associated with Long Covid Symptoms in an Online Cohort Study
por: Durstenfeld, Matthew S., et al.
Publicado: (2022)

Factors Associated With Long COVID Symptoms in an Online Cohort Study
por: Durstenfeld, Matthew S, et al.
Publicado: (2023)

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
por: Hammond, Jennifer, et al.
Publicado: (2022)

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
por: Hung, Yuan-Pin, et al.
Publicado: (2022)

Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications
por: Ross, Sydney B., et al.
Publicado: (2022)

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19
por: Apple, Alexandra C., et al.
Publicado: (2022)

Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
por: Peluso, Michael J., et al.
Publicado: (2022)

Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation
por: Antonelli, Guido, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2cjiunaa0dgde19isbeg96vuo